HOME >> BIOLOGY >> NEWS
Study of flu patients reveals virus outsmarting key drug

MADISON - A drug envisioned as a front-line defense for the next flu pandemic might have a genetic Achilles' heel that results in a drug-resistant influenza virus capable of infecting new human hosts, according to a study published this week (Aug. 28) in the British medical journal The Lancet.

The study of Japanese children with influenza and treated with the antiviral drug oseltamivir was conducted by an international team of researchers led by virologist Yoshihiro Kawaoka of the University of Wisconsin-Madison and the University of Tokyo. Results of the study showed that nearly 20 percent of patients treated with the drug produced mutant drug-resistant viruses as soon as four days after treatment. Moreover, patients continued to shed significant amounts of infectious viral particles even after five days of treatment with the potent antiviral agent.

"The problem with this compound is that a single (genetic) mutation makes the virus resistant," says Kawaoka, an authority on influenza who holds an appointment at the UW-Madison School of Veterinary Medicine.

The finding is important because it provides evidence that influenza viruses can easily and quickly thwart one of the few lines of defense for a disease that claims many lives each year and that, in a pandemic, is among the world's most feared and deadly diseases.

"The importance of this work is that when a pandemic occurs with a new virus and this drug is extensively used, then we may be faced with the rapid appearance of resistant viruses," Kawaoka says.

At present, there are only two strategies for stemming the spread of influenza: vaccines and antiviral drugs. Vaccines use inactivated forms of a virus to ramp up the immune system and thwart infection. Antiviral drugs such as oseltamivir work by inhibiting key proteins on the surface of the virus, effectively locking them in their host cells and preventing the virus from escaping and infecting new cells and hosts.


'"/>

Contact: Yoshihiro Kawaoka
kawaokay@svm.vetmed.wisc.edu
University of Wisconsin-Madison
26-Aug-2004


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study in Science reveals recreational fishing takes big bite of ocean catch
7. Study suggests cell-cycle triggers might be cancer drug targets
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. Study links high carbohydrate diet to increased breast cancer risk
10. Study explains spatial orientation differences between sexes
11. Study suggests humans can speed evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/31/2018)... SAN FRANCISCO (PRWEB) , ... October 30, 2018 , ... ... science, runs this week from Oct. 31 through Nov. 3. The event offers more ... science and thought leaders from top companies striving to advance the state of the ...
(Date:10/26/2018)... ... October 26, 2018 , ... uBiome, the leader in microbial ... Women’s Health Group and prominent women’s health expert, to its Medical Advisory Board. ... Moore will bring to uBiome her expertise on women’s health including risk factors ...
(Date:10/25/2018)... ... 25, 2018 , ... Dovel Technologies announced today ... Center for Biologics Effectiveness and Research (CBER) for the CBER Biologics Effectiveness and ... with respect to data sources, infrastructure, methods, and tools and to conduct active ...
Breaking Biology News(10 mins):
(Date:11/7/2018)... ... November 07, 2018 , ... Since September of this ... awareness of the adult tissue stem cell counting problem in stem cell medicine ... is intensifying this effort with new educational publications and presentations at clinical trial ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings Inc., ... Healthineers and several healthcare VC firms announces at Distributed Health 2018 conference November ... by purchasing tokens and obtaining its first radiology interpretations, one of the first ...
(Date:11/3/2018)... ... ... Triangle Insights Group, a premier life sciences consulting firm, announced today that ... the United States, appearing on this year’s Inc. 5000 list. Since its inception ... over the previous three years. , Separately, Triangle Insights was also ranked on ...
(Date:10/31/2018)... ... October 30, 2018 , ... ... to be a very important aspect of experimental biology. Reproducibility of cell-based assays ... data. Despite of choosing the appropriate assay type, there are many more factors ...
Breaking Biology Technology:
Cached News: